Cognition Disorders Clinical Trial
Official title:
The Influence of Sedation for Endoscopy on Cognitive Function
Verified date | November 2019 |
Source | Shanghai Jiao Tong University School of Medicine |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
It is commonly recommended that patients should refrain from driving for 24 hours after sedation for endoscopy,however,this recommendation has been queried recently.To investigate the effect of sedation on early postoperative cognitive function in patients undergoing endoscopy.
Status | Terminated |
Enrollment | 200 |
Est. completion date | November 14, 2019 |
Est. primary completion date | November 14, 2019 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 20 Years to 64 Years |
Eligibility |
Inclusion Criteria: 1. The scores of MMSE are more than 26. 2. The AHA grade I and II. Exclusion Criteria: 1. The AHA grade III, IV or V. 2. binge drinking. 3. Take sedatives, sleeping agents and some drug which may affect the study in a month. 4. Psychiatric disorders. 5. The dysfunction of heart, lung, liver and kidney. |
Country | Name | City | State |
---|---|---|---|
China | Department of Gastroenterology, Renji Hospital, Shanghai Institute of Digestive Diseases, Shanghai Jiao Tong University School of Medicine | Shanghai | Shanghai |
Lead Sponsor | Collaborator |
---|---|
Shanghai Jiao Tong University School of Medicine |
China,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | NCT-A test outcome measure | the score of NCT-A test for each patient is not less than that in the baseline. | 30 minutes | |
Primary | DST test outcome measure | the score of DST for each patient is not less than that in the baseline. | 30 minutes | |
Primary | number cancellation test outcome measure | the score of number cancellation test for each patient is not less than that in the baseline. | 30 minutes | |
Secondary | heart rate outcome measure | heart rate less than 50 time per minute | 5 minutes | |
Secondary | SpO2 outcome measure | SpO2 less than 90% | 5 minutes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02488720 -
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
|
||
Recruiting |
NCT03544801 -
Renji Cerebral Small Vessel Disease Corhort Study
|
||
Recruiting |
NCT02813434 -
Cerebral Amyloid Imaging Using Florbetapir (AV-45)
|
Phase 3 | |
Completed |
NCT00400790 -
Organ Protection for Coronary Artery Bypass Graft (CABG): Propofol Versus Desflurane
|
N/A | |
Completed |
NCT00052091 -
Therapy for Depressed Elders With Thought Problems
|
Phase 3 | |
Completed |
NCT00267163 -
Brain Imaging and Mental Disorders of Aging Intervention
|
Phase 4 | |
Completed |
NCT00021866 -
Developmental Effects On Children Of Women Who Take Antiepileptic Drugs During Pregnancy
|
N/A | |
Not yet recruiting |
NCT04079075 -
Multiple Interventions to Prevent Cognitive Decline
|
N/A | |
Terminated |
NCT03696082 -
A Precision Rehabilitation Approach to Counteract Age-Related Cognitive Declines
|
N/A | |
Completed |
NCT02918539 -
Registry of Amyloid Positive Patients for Alzheimer's Disease Drug Research Trials
|
||
Active, not recruiting |
NCT01708837 -
Effect of Depth of Total Intravenous Anesthesia Using Propofol on Postoperative Cognitive Dysfunction
|
Phase 4 | |
Completed |
NCT01290939 -
Bevacizumab and Lomustine for Recurrent GBM
|
Phase 3 | |
Terminated |
NCT00548327 -
The Effects of Atomoxetine on Cognition and Brain Function Based on Catechol-O-methyltransferase(COMT) Genotype
|
Phase 2 | |
Unknown status |
NCT00256425 -
Cognitive Rehabilitation of Glioma Patients
|
Phase 3 | |
Recruiting |
NCT03926351 -
High Dose Omega 3 in People at Risk for Dementia
|
Phase 2 | |
Completed |
NCT02118571 -
Schizophrenia Cognition Scale Development
|
N/A | |
Completed |
NCT01481961 -
Study of Repetitive Transcranial Magnetic Stimulation (rTMS) as add-on Treatment for Early Alzheimer's Disease
|
N/A | |
Completed |
NCT00788918 -
Study of Cerebral Function in Patients With Chronic Hepatitis C Infection (HCV/CNS)
|
N/A | |
Completed |
NCT00564902 -
The Zeaxanthin and Visual Function Study
|
N/A | |
Completed |
NCT00529581 -
A Study of C105 on Cognitive Dysfunction in Persons With Multiple Sclerosis
|
Phase 2 |